In the case of breast cancer, women with a higher BMI do have higher rates of recurrence compared to women in the "normal" ...

New weight loss drugs like Ozempic and Wegovy help suppress appetite, leading to significant weight loss, but they come with ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Weight loss drugs like Ozempic, Mounjaro, and Zepbound have changed millions of lives by helping people shed extra pounds ... at losing weight through diet and exercise didn't translate in results ...

(WVUE) - A federal judge’s decision last week to restrict compounding pharmacies from producing tirzepatide, the generic version of Eli Lilly’s weight loss drug Zepbound, has raised concerns ...

equip as many people as possible with the knowledge they need to make informed decisions around weight-loss drugs and to show that changes to your lifestyle and improving your diet is essential to ...

“My hope is that this book might do exactly that: equip as many people as possible with the knowledge they need to make informed decisions around weight-loss drugs and to show that changes to your ...

At 289 pounds, he had struggled to lose weight for years with diet and exercise ... While it’s unclear how many people on these drugs are experiencing vision issues, Norris’s attorney ...

Extreme diets have long been a part of diet culture as quick-fix weight-loss solutions. When I was growing up, these diets were found in women's magazines and often called "fads" as they cycled in ...

The lower price is available to both uninsured patients and people whose insurance does not cover weight-loss drugs, the company also said. Last week, Eli Lilly, the maker of Zepbound, also cut ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. “It’s about the size of a small city,” says David Ricks, Eli Lilly’s CEO. That’s about 10% ...